Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: Clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays

Modern Rheumatology

Volumn 16, Issue 3, 2006, Pages 158-164

  Tsutsumi, Akito ^a   Hayashi, Taichi ^a   Chino, Yusuke ^a   Mamura, Mizuko ^a   Goto, Daisuke ^a   Matsumoto, Isao ^a   Ito, Satoshi ^a   Sumida, Takayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Antiphospholipid syndrome; Antiprothrombin antibody; Enzyme immunoassay; Systemic lupus erythematosus (SLE)

Indexed keywords

BETA2 INTEGRIN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE; PROTHROMBIN ANTIBODY; WARFARIN;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; HUMAN; IMMUNOGLOBULIN PRODUCTION; INTERMETHOD COMPARISON; LIPID ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS; IMMUNOENZYME TECHNIQUES; LUPUS ERYTHEMATOSUS, SYSTEMIC; ODDS RATIO; PHOSPHATIDYLSERINES; PREDICTIVE VALUE OF TESTS; PROTHROMBIN; RISK FACTORS; STATISTICS, NONPARAMETRIC; THROMBOSIS;

EID: 33745045915     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-006-0481-7     Document Type: Article

References (24)

1. EN Harris AE Gharavi ML Boey BM Patel CG Mackworth-Young S Loizou 1983 Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus Lancet 2 1211-4 6139567 1:STN:280:BiuD28nnt1A%3D 10.1016/S0140-6736(83)91267-9
2. T Koike M Sueishi H Funaki H Tomioka S Yoshida 1984 Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus Clin Exp Immunol 56 193-9 6201309 1:STN:280:BiuC1c7hvVY%3D
3. EN Harris AE Gharavi SP Patel GR Hughes 1987 Evaluation of the anti-cardiolipin antibody test: Report of an international workshop held 4 April 1986 Clin Exp Immunol 68 215-22 3652514 1:STN:280:BieD3c3ps1M%3D
4. J Kaburaki M Kuwana M Yamamoto S Kawai E Matsuura Y Ikeda 1995 Clinical significance of phospholipid-dependent anti-β2-glycoprotein I (β2-GPI) antibodies in systemic lupus erythematosus Lupus 4 472-6 8749570 1:CAS:528:DyaK28Xhs1Sru7w%3D
5. J Kaburaki M Kuwana M Yamamoto S Kawai E Matsuura Y Ikeda 1996 Phospholipid-dependent anti-β2-glycoprotein I (β2-GPI) antibodies and antiphospholipid syndrome Intern Med 35 105-10 8680096 1:STN:280:BymB2snhtVc%3D
6. K Aoki AB Dudkiewicz E Matsuura M Novotny G Kaberlein N Gleicher 1995 Clinical significance of β2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: Correlation with conventional antiphospholipid antibody detection systems Am J Obstet Gynecol 172 926-31 7892887 1:STN:280:ByqB3c%2FgtVE%3D 10.1016/0002-9378(95)90023-3
7. WA Wilson AE Gharavi T Koike MD Lockshin DW Branch JC Piette 1999 International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop Arthritis Rheum 42 1309-11 10403256 1:STN:280:DyaK1MzjtVSmsg%3D%3D 10.1002/ 1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F
8. ME Martinuzzo RR Forastiero LO Carreras 1995 Anti β2-glycoprotein I antibodies: Detection and association with thrombosis Br J Haematol 89 397-402 7873391 1:CAS:528:DyaK2MXkvVSrur4%3D
9. V Pengo A Biasiolo MG Fior 1995 Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface Thromb Haemost 73 29-34 7537919 1:CAS:528:DyaK2MXjtFSkurw%3D
10. A Tsutsumi E Matsuura K Ichikawa A Fujisaku M Mukai S Kobayashi 1996 Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus Arthritis Rheum 39 1466-74 8814057 1:STN:280:BymH3cbgslA%3D
11. O Amengual T Atsumi MA Khamashta T Koike GR Hughes 1996 Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphospholipid syndrome Br J Rheumatol 35 1239-43 9010050 1:CAS:528:DyaK2sXnvFamsA%3D%3D 10.1093/rheumatology/35.12.1239
12. SS Sanfilippo MA Khamashta T Atsumi O Amengual ML Bertolaccini D D'Cruz 1998 Antibodies to β2-glycoprotein I: A potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus J Rheumatol 25 2131-4 9818654 1:STN:280:DyaK1M%2Fjtl2lsQ%3D%3D
13. E Matsuura Y Igarashi M Fujimoto K Ichikawa T Koike 1990 Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease Lancet 336 177-8 1973491 1:STN:280:By%2BA3Mfhsl0%3D 10.1016/0140-6736(90)91697-9
14. HP McNeil RJ Simpson CN Chesterman SA Krilis 1990 Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H) Proc Natl Acad Sci USA 87 4120-4 2349221 1:CAS:528:DyaK3cXktlymtbo%3D 10.1073/pnas.87.11.4120
15. M Galli P Comfurius C Maassen HC Hemker MH de Baets PJ van Breda-Vriesman 1990 Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor Lancet 335 1544-7 1972485 1:STN:280:By%2BB1cnns1Y%3D 10.1016/0140-6736(90)91374-J
16. EM Bevers M Galli T Barbui P Comfurius RF Zwaal 1991 Lupus anticoagulant IgGs (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin Thromb Haemost 66 629-32 1796407 1:CAS:528:DyaK38XhtVChs78%3D
17. M Galli D Luciani G Bertolini T Barbui 2003 Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome Blood 102 2717-23 12816875 1:CAS:528:DC%2BD3sXotF2ntLc%3D 10.1182/blood-2002-11-3334
18. T Atsumi M Ieko ML Bertolaccini K Ichikawa A Tsutsumi E Matsuura 2000 Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant Arthritis Rheum 43 1982-93 11014348 1:CAS:528:DC%2BD3cXnt1Kns7g%3D 10.1002/ 1529-0131(200009)43:9<1982::AID-ANR9>3.0.CO;2-2
19. ML Bertolaccini T Atsumi T Koike GR Hughes MA Khamashta 2005 Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus Thromb Haemost 93 289-97 15711745 1:CAS:528:DC%2BD2MXhs1Knsro%3D
20. EM Tan AS Cohen JF Fries AT Masi DJ McShane NF Rothfield 1982 The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 25 1271-7 7138600 1:STN:280:BiyD2cfksFI%3D
21. MC Hochberg 1997 Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 40 17259324032 1:STN:280:ByiH28vitFU%3D
22. J Kaburaki M Kuwana R Uehara K Ohya 2002 Development of ELISA kit to examine anti-phosphatidylserine/prothrombin complex antibodies (antiprothrombin antibodies) (in Japanese) Jpn J Med Pharm Sci 47 813-9 1:CAS:528:DC%2BD38Xmt1Cku7o%3D
23. T Exner G Papadopoulos J Koutts 1990 Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among "lupus anticoagulants" Blood Coagul Fibrinolysis 1 259-66 2129412 1:STN:280:By6A2Mrlt1M%3D
24. A Tsutsumi K Ichikawa T Atsumi E Matsuura T Koike SA Krilis 1998 Use of various methods for anticardiolipin detection in the updated American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: Comment on the letter by Hochberg Arthritis Rheum 41 1326-7 9663496 1:STN:280:DyaK1czis1Khuw%3D%3D 10.1002/ 1529-0131(199807)41:7<1326::AID-ART29>3.0.CO;2-4